Not Rated
|
Fund Size
(0.06% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 31-Oct-25 | 9985.70 | -0.14% | - | -0.83% | 46/240 |
| 1 Month | 07-Oct-25 | 10087.40 | 0.87% | - | 0.83% | 125/246 |
| 3 Month | 07-Aug-25 | 10244.40 | 2.44% | - | 3.74% | 174/243 |
| 6 Month | 07-May-25 | 10674.60 | 6.75% | - | 8.55% | 142/232 |
| YTD | 01-Jan-25 | 9714.80 | -2.85% | - | 3.55% | 175/219 |
| Since Inception | 27-Dec-24 | 9810.00 | -1.90% | -2.20% | 12.22% | 204/218 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Pharmaceuticals | 250 | 7.75% | -0.11% | 9.27% (Apr 2025) | 0% (Oct 2024) | 43.94 k | 1.52 k |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 242.7 | 7.53% | 0.32% | 8.83% (Apr 2025) | 0% (Oct 2024) | 1.52 L | 2.60 k |
| - Apollo Hospitals Enterprises Ltd. | Hospital | 202.7 | 6.29% | 0.00% | 6.29% (Sep 2025) | 0% (Oct 2024) | 27.36 k | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 175.6 | 5.45% | -0.16% | 8.33% (Apr 2025) | 0% (Oct 2024) | 1.17 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 123.6 | 3.83% | 0.32% | 3.83% (Sep 2025) | 0% (Oct 2024) | 1.27 L | 0.00 |
| Neuland Laboratories Ltd. | Pharmaceuticals | 121.8 | 3.78% | 0.53% | 3.78% (Sep 2025) | 0% (Oct 2024) | 8.34 k | 350.00 |
| Biocon Ltd. | Pharmaceuticals | 115.8 | 3.59% | 0.14% | 4.24% (Jan 2025) | 0% (Oct 2024) | 3.40 L | 12.00 k |
| Aurobindo Pharma Ltd. : Futures Near | Pharmaceuticals | 110.8 | 3.44% | 0.00% | 3.44% (Sep 2025) | 0% (Oct 2024) | 1.02 L | 1.02 L |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 110.7 | 3.43% | -0.01% | 8.46% (Jan 2025) | 0% (Oct 2024) | 90.44 k | 0.00 |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals | 105 | 3.26% | -0.19% | 3.45% (Aug 2025) | 0% (Oct 2024) | 82.00 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 2.97% |
| Net Receivables | Net Receivables | -1.72% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 406.67 | 1.45 | 18.38 | 60.19 | 40.18 | 39.33 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 266.19 | -1.76 | 3.69 | 18.39 | 25.72 | 17.19 |
| Franklin Asian Equity Fund - Growth | NA | 279.13 | 1.36 | 10.62 | 23.02 | 19.68 | 15.60 |
| Nippon India Japan Equity Fund - Growth | NA | 289.73 | -0.93 | 5.46 | 14.11 | 19.10 | 18.32 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1651.55 | -0.47 | 10.77 | 24.49 | 18.71 | 0.00 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 655.17 | 4.82 | 7.47 | 21.51 | 18.29 | 0.00 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1419.62 | 3.49 | 7.22 | 9.88 | 16.52 | 0.00 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 311.03 | 4.43 | 7.14 | 8.73 | 15.69 | 13.41 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8693.07 | 2.81 | 5.84 | 11.12 | 15.33 | 19.07 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2014.27 | 3.56 | 5.37 | 9.44 | 13.33 | 17.15 |
Out of 23 mutual fund schemes offered by this AMC, 2 is/are ranked 4 * , 1 is/are ranked 3 * , and 20 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Bajaj Finserv Flexi Cap Fund - Regular Plan - Growth | NA | 5632.23 | 2.01 | 4.35 | 11.45 | 6.13 | 0.00 |
| Bajaj Finserv Liquid Fund - Regular Plan - Growth | 4 | 5196.19 | 0.46 | 1.41 | 2.95 | 6.56 | 0.00 |
| Bajaj Finserv Money Market Fund - Regular Plan - Growth | 4 | 5177.96 | 0.43 | 1.32 | 3.08 | 7.09 | 0.00 |
| Bajaj Finserv Large and Mid Cap Fund - Regular Plan - Growth | NA | 2125.78 | 2.29 | 3.24 | 6.85 | 3.34 | 0.00 |
| Bajaj Finserv Large Cap Fund - Regular Plan - Growth | NA | 1603.94 | 2.60 | 5.49 | 6.92 | 4.14 | 0.00 |
| Bajaj Finserv Small Cap Fund - Regular Plan - Growth | NA | 1378.47 | 1.29 | 2.22 | 0.00 | 0.00 | 0.00 |
| Bajaj Finserv Arbitrage Fund - Regular Plan - Growth | 3 | 1295.52 | 0.56 | 1.39 | 2.68 | 6.01 | 0.00 |
| Bajaj Finserv Balanced Advantage - Regular Plan - Growth | NA | 1285.76 | 2.21 | 4.24 | 5.44 | 4.52 | 0.00 |
| Bajaj Finserv Multi Asset Allocation Fund - Regular Plan - Growth | NA | 1216.11 | 1.90 | 7.06 | 9.66 | 9.78 | 0.00 |
| Bajaj Finserv Multi Asset Allocation Fund - Regular Plan - Growth | NA | 1216.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |